John Epoh Dibato1, Olga Montvida1, Francesco Zaccardi2, Jack Alistair Sargeant2,3, Melanie J Davies2,3, Kamlesh Khunti2,3, Sanjoy K Paul4. 1. Melbourne EpiCentre, University of Melbourne and Melbourne Health, Melbourne, Victoria, Australia. 2. Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, U.K. 3. Leicester NIHR Biomedical Research Centre, Leicester, U.K. 4. Melbourne EpiCentre, University of Melbourne and Melbourne Health, Melbourne, Victoria, Australia sambhupaul@hotmail.com.
Abstract
OBJECTIVE: To evaluate the temporal patterns of cardiometabolic multimorbidity (CM) and depression in white Caucasians (WCs) and African Americans (AAs) with early-onset type 2 diabetes and their impact on long-term atherosclerotic cardiovascular disease (ASCVD). RESEARCH DESIGN AND METHODS: From U.S. electronic medical records, 101,104 AA and 505,336 WC subjects with type 2 diabetes diagnosed between 2000 and 2017 were identified (mean follow-up 5.3 years). Among those without ASCVD at diagnosis, risk of ASCVD and three-point major adverse cardiovascular events (MACE-3) (heart failure, myocardial infarction, or stroke) was evaluated between ethnicities by age-groups. RESULTS: The proportion of patients diagnosed at <50 years of age increased during 2012-2017 (AA 34-38%, WC 26-29%). Depression prevalence increased during 2000-2017 (AA 15-23%, WC 20-34%), with an increasing trend for CM at diagnosis in both groups. Compared with WC, the adjusted MACE-3 risk was significantly higher in AA across all age-groups, more pronounced in the 18-39-year age-group (hazard ratio 95% CI 1.42, 1.88), and in patients with and without depression. AAs had a 17% (1.05, 1.31) significantly higher adjusted ASCVD risk in the 18-39-year age-group only. Depression was independently associated with ASCVD and MACE-3 risk in both ethnic groups across all age-groups. Other comorbidities were independently associated with ASCVD and MACE-3 risk only among WCs. CONCLUSIONS: AAs have higher cardiovascular risk compared with WCs, particularly in early-onset type 2 diabetes. CM and depression at diabetes diagnosis have been increasing over the past two decades in both ethnic groups. Strategies for screening and optimal management of CM and depression, particularly in early-onset type 2 diabetes, may result in a lower cardiovascular risk.
OBJECTIVE: To evaluate the temporal patterns of cardiometabolic multimorbidity (CM) and depression in white Caucasians (WCs) and African Americans (AAs) with early-onset type 2 diabetes and their impact on long-term atherosclerotic cardiovascular disease (ASCVD). RESEARCH DESIGN AND METHODS: From U.S. electronic medical records, 101,104 AA and 505,336 WC subjects with type 2 diabetes diagnosed between 2000 and 2017 were identified (mean follow-up 5.3 years). Among those without ASCVD at diagnosis, risk of ASCVD and three-point major adverse cardiovascular events (MACE-3) (heart failure, myocardial infarction, or stroke) was evaluated between ethnicities by age-groups. RESULTS: The proportion of patients diagnosed at <50 years of age increased during 2012-2017 (AA 34-38%, WC 26-29%). Depression prevalence increased during 2000-2017 (AA 15-23%, WC 20-34%), with an increasing trend for CM at diagnosis in both groups. Compared with WC, the adjusted MACE-3 risk was significantly higher in AA across all age-groups, more pronounced in the 18-39-year age-group (hazard ratio 95% CI 1.42, 1.88), and in patients with and without depression. AAs had a 17% (1.05, 1.31) significantly higher adjusted ASCVD risk in the 18-39-year age-group only. Depression was independently associated with ASCVD and MACE-3 risk in both ethnic groups across all age-groups. Other comorbidities were independently associated with ASCVD and MACE-3 risk only among WCs. CONCLUSIONS: AAs have higher cardiovascular risk compared with WCs, particularly in early-onset type 2 diabetes. CM and depression at diabetes diagnosis have been increasing over the past two decades in both ethnic groups. Strategies for screening and optimal management of CM and depression, particularly in early-onset type 2 diabetes, may result in a lower cardiovascular risk.
Authors: EunSeok Cha; Francisco J Pasquel; Fengxia Yan; David R Jacobs; Sandra B Dunbar; Guillermo Umpierrez; Yuni Choi; James M Shikany; Michael P Bancks; Jared P Reis; Melissa Spezia Faulkner Journal: Diabetes Res Clin Pract Date: 2021-11-11 Impact factor: 5.602
Authors: Can Hou; Huazhen Yang; Yuanyuan Qu; Wenwen Chen; Yu Zeng; Yao Hu; K M Venkat Narayan; Huan Song; Dong Li Journal: Precis Clin Med Date: 2022-06-06
Authors: John Dibato; Olga Montvida; Joanna Ling; Digsu Koye; William H Polonsky; Sanjoy K Paul Journal: Diabetologia Date: 2022-09-05 Impact factor: 10.460
Authors: Li Gong; Tianqi Ma; Lingfang He; Guoqiang Lin; Guogang Zhang; Xunjie Cheng; Fanyan Luo; Yongping Bai Journal: Front Public Health Date: 2022-08-04